Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Cryo Cell International (CCEL) over the last 15 years, with Q3 2025 value amounting to -$3.5 million.

  • Cryo Cell International's Cash from Financing Activities fell 7194.4% to -$3.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$4.5 million, marking a year-over-year decrease of 14352.75%. This contributed to the annual value of -$979118.0 for FY2024, which is 5276.56% up from last year.
  • Latest data reveals that Cryo Cell International reported Cash from Financing Activities of -$3.5 million as of Q3 2025, which was down 7194.4% from $710155.0 recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Cash from Financing Activities registered a high of $8.7 million during Q3 2022, and its lowest value of -$5.6 million during Q4 2022.
  • Its 5-year average for Cash from Financing Activities is -$514998.4, with a median of -$775000.0 in 2021.
  • Data for Cryo Cell International's Cash from Financing Activities shows a peak YoY increase of 121707.9% (in 2022) and a maximum YoY decrease of 147604.35% (in 2022) over the last 5 years.
  • Cryo Cell International's Cash from Financing Activities (Quarter) stood at -$814250.0 in 2021, then plummeted by 583.58% to -$5.6 million in 2022, then surged by 72.32% to -$1.5 million in 2023, then soared by 56.0% to -$677821.0 in 2024, then plummeted by 418.37% to -$3.5 million in 2025.
  • Its Cash from Financing Activities stands at -$3.5 million for Q3 2025, versus $710155.0 for Q2 2025 and -$1.0 million for Q1 2025.